Today: 5. Nov, 2024
Investors seeking growth opportunities without breaking the bank often look to stocks with high potential that trade for under $100. Whether these companies have undergone stock splits or are simply undervalued, they present a unique opportunity for those willing to invest in…
In a significant strategic move, pharmaceutical giant Johnson & Johnson has announced a definitive agreement to acquire Ambrx Biopharma, a pioneering cancer drug developer, for an impressive $2 billion in cash. This acquisition, revealed on the first day of the annual JPMorgan…
